Registry Links KIT Inhibition to Lower AML Transformation in SM-AHN

Company International registry investigators (academic) Event Type Peer-reviewed publication (Blood) Modality KIT D816V-selective tyrosine kinase inhibitors (class exposure) Asset Not applicable (registry analysis) Target KIT D816V Disease Area Systemic mastocytosis with associated hematologic neoplasm Summary Source-gap recovery: a peer-reviewed Blood research article appeared online November…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *